FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
scientific article
Author/s
author: Anita Grigoriadis, Andrew Tutt, Cheryl Gillett, Rachael Natrajan, Elizabeth Iorns, Alan Ashworth, Jorge Reis-Filho, Caterina Marchiò, Felipe C Geyer, Maryou B K Lambros, Alex Pearson, Rachel Sharpe
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.